Profile data is unavailable for this security.
About the company
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion reagent cocktail preparation system; the flow cytometer and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Cytek Northern Lights systems are flow cytometers that deliver high-resolution, high-content, and high-sensitivity cell analysis. Its Cytek Aurora CS is a cell sorter that leverages the detection and sensitivity capabilities of its FSP technology to isolate living cell populations from lower to higher complexity panels beyond 40 biomarkers.
- Revenue in USD (TTM)193.01m
- Net income in USD-12.15m
- Incorporated2014
- Employees676.00
- LocationCytek Biosciences Inc47215 LAKEVIEW BOULEVARDFREMONT 94538United StatesUSA
- Websitehttps://cytekbio.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fulgent Genetics Inc | 289.21m | -167.83m | 646.03m | 1.18k | -- | 0.5661 | -- | 2.23 | -5.64 | -5.64 | 9.71 | 38.31 | 0.2207 | -- | 5.57 | 244,267.70 | -13.37 | 16.70 | -14.25 | 18.37 | 36.12 | 67.89 | -60.59 | 29.06 | -- | -- | 0.0048 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
SI-Bone Inc | 138.89m | -43.34m | 649.64m | 344.00 | -- | 3.80 | -- | 4.68 | -1.13 | -1.13 | 3.62 | 4.16 | 0.716 | 1.57 | 6.52 | 403,738.40 | -22.34 | -27.88 | -25.24 | -30.94 | 78.78 | 85.03 | -31.20 | -51.09 | 8.15 | -- | 0.1756 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
Orthopediatrics Corp | 148.73m | -20.97m | 682.23m | 247.00 | -- | 1.80 | -- | 4.59 | -0.9251 | -0.9251 | 6.56 | 16.13 | 0.3433 | 0.4073 | 5.01 | 602,153.90 | -4.84 | -5.40 | -5.28 | -5.93 | 74.80 | 75.09 | -14.10 | -15.92 | 2.90 | -- | 0.026 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
Perspective Therapeutics Inc | 8.17m | -25.10m | 702.39m | 88.00 | -- | 3.41 | -- | 85.96 | -0.1012 | -0.1012 | 0.0351 | 0.352 | 0.0944 | 4.91 | 5.55 | 92,852.27 | -29.01 | -- | -31.19 | -- | 22.96 | -- | -307.18 | -- | 2.55 | -- | 0.0173 | -- | -- | -- | -- | -- | -- | -- |
Varex Imaging Corp | 877.80m | 44.60m | 715.78m | 2.30k | 26.27 | 1.26 | 9.06 | 0.8154 | 0.6712 | 0.6712 | 16.65 | 14.01 | 0.7245 | 1.95 | 5.90 | 365,750.00 | 3.72 | 0.9913 | 4.32 | 1.18 | 32.37 | 31.70 | 5.14 | 1.36 | 2.37 | 2.85 | 0.4322 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
Silk Road Medical Inc | 177.13m | -55.74m | 732.96m | 474.00 | -- | 4.85 | -- | 4.14 | -1.44 | -1.44 | 4.56 | 3.86 | 0.6622 | 2.04 | 8.52 | 373,700.40 | -20.84 | -29.02 | -23.22 | -32.98 | 71.75 | 72.91 | -31.47 | -46.84 | 6.97 | -- | 0.3335 | -- | 27.77 | 38.66 | -1.33 | -- | -7.92 | -- |
Embecta Corp | 1.12bn | 55.30m | 742.77m | 2.20k | 13.44 | -- | 8.26 | 0.6618 | 0.9598 | 0.9598 | 19.47 | -13.78 | 0.9296 | 2.57 | 19.35 | 510,181.80 | 4.58 | -- | 6.44 | -- | 66.55 | -- | 4.93 | -- | 1.75 | 1.67 | 1.94 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
Treace Medical Concepts Inc | 187.12m | -49.53m | 763.29m | 516.00 | -- | 5.53 | -- | 4.08 | -0.8154 | -0.8154 | 3.08 | 2.23 | 0.9107 | 1.45 | 5.56 | 362,631.80 | -24.10 | -- | -29.51 | -- | 81.20 | -- | -26.47 | -- | 3.76 | -- | 0.2776 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
Atrion Corp | 169.33m | 19.41m | 788.41m | 712.00 | 40.65 | 3.25 | 22.85 | 4.66 | 11.02 | 11.02 | 96.13 | 138.01 | 0.6444 | 1.44 | 7.21 | 237,817.40 | 7.39 | 11.96 | 7.85 | 12.62 | 36.84 | 41.99 | 11.46 | 19.05 | 2.57 | 92.92 | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
BioLife Solutions Inc | 143.27m | -66.43m | 836.24m | 409.00 | -- | 2.47 | -- | 5.84 | -1.52 | -1.52 | 3.28 | 7.48 | 0.332 | 2.46 | 5.45 | 350,298.30 | -15.40 | -13.76 | -17.12 | -15.04 | 32.63 | 36.76 | -46.36 | -42.99 | 1.83 | -30.52 | 0.0733 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
Cytek Biosciences Inc | 193.01m | -12.15m | 867.36m | 676.00 | -- | 2.20 | -- | 4.49 | -0.0887 | -0.0887 | 1.43 | 3.01 | 0.3807 | 1.53 | 3.68 | 285,523.70 | -2.40 | -- | -2.67 | -- | 56.69 | -- | -6.29 | -- | 5.89 | -- | 0.0056 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
Artivion Inc | 354.00m | -30.57m | 891.70m | 1.50k | -- | 3.15 | -- | 2.52 | -0.7496 | -0.7496 | 8.68 | 6.86 | 0.4553 | 1.60 | 5.30 | 236,002.70 | -3.95 | -2.20 | -4.24 | -2.36 | 64.74 | 65.51 | -8.67 | -5.34 | 3.43 | 0.6809 | 0.5246 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
Avanos Medical Inc | 673.30m | -9.90m | 919.46m | 3.77k | -- | 0.7432 | 25.40 | 1.37 | -0.2092 | -1.32 | 14.43 | 26.77 | 0.387 | 1.66 | 4.73 | 178,546.80 | -0.5691 | -0.6527 | -0.6473 | -0.7338 | 56.39 | 54.45 | -1.47 | -1.60 | 1.38 | 4.27 | 0.1196 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
Paragon 28 Inc | 216.39m | -47.84m | 986.59m | 463.00 | -- | 5.55 | -- | 4.56 | -0.5816 | -0.5816 | 2.64 | 2.15 | 0.7276 | 0.5484 | 5.77 | -- | -16.09 | -- | -20.14 | -- | 79.85 | -- | -22.11 | -- | 2.30 | -7.22 | 0.3832 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
Pacific Biosciences of California Inc | 200.52m | -306.74m | 996.78m | 796.00 | -- | 1.42 | -- | 4.97 | -1.21 | -1.21 | 0.7907 | 2.62 | 0.1142 | 2.70 | 7.24 | 251,910.80 | -17.46 | -16.19 | -19.45 | -17.81 | 28.03 | 37.35 | -152.97 | -136.21 | 7.21 | -22.45 | 0.5601 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Fund Advisorsas of 31 Dec 2023 | 16.62m | 12.26% |
Brown Capital Management LLCas of 31 Dec 2023 | 12.02m | 8.87% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 11.58m | 8.54% |
RA Capital Management LPas of 31 Dec 2023 | 6.81m | 5.02% |
HHLR Advisors Ltd.as of 31 Dec 2023 | 6.66m | 4.91% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 4.00m | 2.95% |
New York State Common Retirement Fundas of 31 Dec 2023 | 2.95m | 2.18% |
Geode Capital Management LLCas of 31 Dec 2023 | 2.46m | 1.81% |
Wellington Management Co. LLPas of 31 Dec 2023 | 1.29m | 0.95% |
Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023 | 1.18m | 0.87% |